Global circumferential and radial strain among patients with immune checkpoint inhibitor myocarditis
Background Global circumferential strain (GCS) and global radial strain (GRS) are reduced
with cytotoxic chemotherapy. There are limited data on the effect of immune checkpoint …
with cytotoxic chemotherapy. There are limited data on the effect of immune checkpoint …
[HTML][HTML] Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib
Q Xing, Z Zhang, B Zhu, Q Lin, L Shen, F Li… - Frontiers in …, 2022 - frontiersin.org
Introduction Immune therapy has ushered in a new era of tumor treatment, at the expense of
immune-related adverse events, including rare but fatal adverse cardiovascular events, such …
immune-related adverse events, including rare but fatal adverse cardiovascular events, such …
Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors
AH Baik, KK Tsai, DY Oh, MA Aras - Clinical Science, 2021 - portlandpress.com
Immunotherapies have greatly expanded the armamentarium of cancer-directed therapies in
the past decade, allowing the immune system to recognize and fight cancer. Immune …
the past decade, allowing the immune system to recognize and fight cancer. Immune …
Temporal trends and outcomes among patients admitted for immune-related adverse events: a single-center retrospective cohort study from 2011 to 2018
Background The aim of this study was to characterize severe immune-related adverse
events (irAEs) seen among hospitalized patients and to examine risk factors for irAE …
events (irAEs) seen among hospitalized patients and to examine risk factors for irAE …
[HTML][HTML] Immune checkpoint inhibitors-associated myocarditis: diagnosis, treatment and current status on rechallenge
F Frascaro, N Bianchi, F Sanguettoli, F Marchini… - Journal of Clinical …, 2023 - mdpi.com
Immune checkpoint molecules like cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed
cell death 1 (PD-1) or its ligand, programmed cell death ligand 1 (PD-L1), play a critical role …
cell death 1 (PD-1) or its ligand, programmed cell death ligand 1 (PD-L1), play a critical role …
[HTML][HTML] Brazilian Society of Cardiology Guideline on Myocarditis–2022
MW Montera, FG Marcondes-Braga… - Arquivos Brasileiros …, 2022 - SciELO Brasil
SciELO - Brasil - Diretriz de Miocardites da Sociedade Brasileira de Cardiologia – 2022 Diretriz
de Miocardites da Sociedade Brasileira de Cardiologia – 2022 Acessibilidade / Reportar erro …
de Miocardites da Sociedade Brasileira de Cardiologia – 2022 Acessibilidade / Reportar erro …
Cardiotoxicity in cancer immune-checkpoint therapy: Mechanisms, clinical evidence, and management strategies
JY Sun, Q Qu, YX Lou, Y Hua, GZ Sun, W Sun… - International Journal of …, 2021 - Elsevier
Abstract Immune-checkpoint inhibitors (ICIs), a unique antibody-based therapeutic strategy,
have revolutionized the treatment landscape of solid and hematological cancers. Despite …
have revolutionized the treatment landscape of solid and hematological cancers. Despite …
[HTML][HTML] The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management
M Roberto, M Panebianco, AM Aschelter… - Frontiers in …, 2023 - frontiersin.org
The new landscape of treatments for metastatic clear cell renal carcinoma (mRCC) is
constantly expanding, but it is associated with the emergence of novel toxicities, adding to …
constantly expanding, but it is associated with the emergence of novel toxicities, adding to …
[HTML][HTML] Toxicity of immune-checkpoint inhibitors in hematological malignancies
K Hradska, R Hajek, T Jelinek - Frontiers in Pharmacology, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICIs), especially those targeting the programmed-death 1 (PD-
1) receptor and its ligands, have become indispensable agents in solid tumor anti-cancer …
1) receptor and its ligands, have become indispensable agents in solid tumor anti-cancer …
Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?
Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?
Page 1 ..................................................................................... Are we underestimating the potential for …
Page 1 ..................................................................................... Are we underestimating the potential for …